These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 27344719)

  • 1. [Molecular and anatomical mechanism of bone metastasis in prostate cancer].
    Yokomizo A; Shiota M
    Nihon Rinsho; 2016 May; 74 Suppl 3():145-8. PubMed ID: 27344719
    [No Abstract]   [Full Text] [Related]  

  • 2. [Molecules associated with invasion and metastasis in prostate cancer].
    Ashida S; Inoue K; Shuin T
    Nihon Rinsho; 2016 May; 74 Suppl 3():135-9. PubMed ID: 27344717
    [No Abstract]   [Full Text] [Related]  

  • 3. Formation of vasculogenic mimicry in bone metastasis of prostate cancer: correlation with cell apoptosis and senescence regulation pathways.
    Luo F; Yang K; Liu RL; Meng C; Dang RF; Xu Y
    Pathol Res Pract; 2014 May; 210(5):291-5. PubMed ID: 24581724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanism of prostate cancer invasion and metastasis].
    Sakamoto S; Ichikawa T
    Nihon Rinsho; 2014 Dec; 72(12):2086-9. PubMed ID: 25518338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A microRNA code for prostate cancer metastasis.
    Bonci D; Coppola V; Patrizii M; Addario A; Cannistraci A; Francescangeli F; Pecci R; Muto G; Collura D; Bedini R; Zeuner A; Valtieri M; Sentinelli S; Benassi MS; Gallucci M; Carlini P; Piccolo S; De Maria R
    Oncogene; 2016 Mar; 35(9):1180-92. PubMed ID: 26073083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGFβ Induces a Pro-Bone Metastasis Program in Prostate Cancer.
    Cancer Discov; 2015 Jul; 5(7):OF23. PubMed ID: 26022606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial plasticity in prostate cancer: principles and clinical perspectives.
    Das R; Gregory PA; Hollier BG; Tilley WD; Selth LA
    Trends Mol Med; 2014 Nov; 20(11):643-51. PubMed ID: 25262538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of osteoblastic bone metastases from prostate cancer.
    Ibrahim T; Flamini E; Mercatali L; Sacanna E; Serra P; Amadori D
    Cancer; 2010 Mar; 116(6):1406-18. PubMed ID: 20108337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HEF1 promotes epithelial mesenchymal transition and bone invasion in prostate cancer under the regulation of microRNA-145.
    Guo W; Ren D; Chen X; Tu X; Huang S; Wang M; Song L; Zou X; Peng X
    J Cell Biochem; 2013 Jul; 114(7):1606-15. PubMed ID: 23355420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding bone metastases: the key to the effective treatment of prostate cancer.
    Fidler IJ
    Clin Adv Hematol Oncol; 2003 May; 1(5):278-9. PubMed ID: 16224421
    [No Abstract]   [Full Text] [Related]  

  • 11. Ecological paradigms to understand the dynamics of metastasis.
    Amend SR; Roy S; Brown JS; Pienta KJ
    Cancer Lett; 2016 Sep; 380(1):237-42. PubMed ID: 26458994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis.
    Darash-Yahana M; Pikarsky E; Abramovitch R; Zeira E; Pal B; Karplus R; Beider K; Avniel S; Kasem S; Galun E; Peled A
    FASEB J; 2004 Aug; 18(11):1240-2. PubMed ID: 15180966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discoidin domain receptor 2 facilitates prostate cancer bone metastasis via regulating parathyroid hormone-related protein.
    Yan Z; Jin S; Wei Z; Huilian H; Zhanhai Y; Yue T; Juan L; Jing L; Libo Y; Xu L
    Biochim Biophys Acta; 2014 Sep; 1842(9):1350-63. PubMed ID: 24787381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
    Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R
    Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanism of invasion and metastasis of prostate cancer: over view].
    Kanayama H
    Nihon Rinsho; 2016 May; 74 Suppl 3():129-34. PubMed ID: 27344716
    [No Abstract]   [Full Text] [Related]  

  • 16. The epithelial-mesenchymal transition-inducing factor TWIST is an attractive target in advanced and/or metastatic bladder and prostate cancers.
    Wallerand H; Robert G; Pasticier G; Ravaud A; Ballanger P; Reiter RE; Ferrière JM
    Urol Oncol; 2010; 28(5):473-9. PubMed ID: 19272800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour angiogenesis in prostatic carcinoma with and without bone marrow metastasis: a morphometric study.
    Wakui S; Furusato M; Itoh T; Sasaki H; Akiyama A; Kinoshita I; Asano K; Tokuda T; Aizawa S; Ushigome S
    J Pathol; 1992 Nov; 168(3):257-62. PubMed ID: 1281874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone metastasis in prostate cancer: molecular and cellular mechanisms (Review).
    Ye L; Kynaston HG; Jiang WG
    Int J Mol Med; 2007 Jul; 20(1):103-11. PubMed ID: 17549396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGF-8 is involved in bone metastasis of prostate cancer.
    Valta MP; Tuomela J; Bjartell A; Valve E; Väänänen HK; Härkönen P
    Int J Cancer; 2008 Jul; 123(1):22-31. PubMed ID: 18386787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of tissue factor is associated with clinical features and angiogenesis in prostate cancer.
    Ohta S; Wada H; Nakazaki T; Maeda Y; Nobori T; Shiku H; Nakamura S; Nagakawa O; Furuya Y; Fuse H
    Anticancer Res; 2002; 22(5):2991-6. PubMed ID: 12530031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.